Home › Endometrial Cancer › Texas › Irving
Endometrial Cancer clinical trials in Irving, TX
6 studies for Endometrial Cancer are looking for participants at sites in and around Irving (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecruitingPhase 1
- NEXT Texas LLC - Dallas, Irving
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
RecruitingPhase 3
- US Oncology Investigational Products Center (IPC), Irving
Phase 1 Study of STRO-006 in Adults With Refractory Solid Tumors That Are Recurrent or Metastatic
RecruitingPhase 1
- NEXT Oncology Dallas, Irving
A Study of PHST001 in Advanced Solid Tumors
RecruitingPhase 1
- NEXT Oncology - Dallas, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecruitingPhase 1/2
- NEXT Dallas, Irving
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
RecruitingPhase 1
- NEXT Oncology, Irving
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY54 studies
- Boston, MA51 studies
- Arlington, VA41 studies
- Nashville, TN38 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- Oklahoma City, OK28 studies
- San Antonio, TX27 studies
- Queens, NY26 studies
- Dallas, TX25 studies
Other studies in Irving
- Non-Small Cell Lung Cancer23 studies
- Colorectal Cancer15 studies
- Cancer (all types)14 studies
- Metastatic Cancer10 studies
- Stomach Cancer9 studies
- Head and Neck Squamous Cell Carcinoma8 studies
- Breast Cancer8 studies
- Pancreatic Cancer7 studies
- Ovarian Cancer7 studies
- Small Cell Lung Cancer6 studies
- Esophageal Cancer5 studies
- Lung Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.